Nuvation Bio
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nuvation Bio generated cash of -$67,999,000, which is more than the previous year. Cash used in financing activities reached the amount of $628,000 last year. Net change in cash is therefore -$58,450,000.

Cash Flow

Nuvation Bio Inc. (NYSE:NUVB): Cash Flow
2019 -24.43M -115.85M 143.61M
2020 -36.52M -70.32M 133.13M
2021 -68.19M -454.66M 625.52M
2022 -96.10M 63.45M 1.32M
2023 -67.99M 8.92M 628K

NUVB Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
101.09M132.42M29.75M3.46M137.86K
Operating activities
Net income
-75.80M-104.19M-86.84M-41.65M-33.55M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
222K199K184K103K13K
Stock-based compensation expense
19.51M16.29M9.26M2.20M0
Deferred income tax benefit 19.51M16.29M9.26M2.20M0
Changes in operating assets and liabilities:
Accounts receivable, net
0554K-1.94M-264K0
Inventories
0-554K1.94M264K0
Accounts payable
70K-1.78M1.86M34K0
Cash generated by operating activities
-67.99M-96.10M-68.19M-36.52M-24.43M
Investing activities
Purchases Of Investments
-703.37M-520.30M-609.3M-143.28M0
Investments In Property Plant And Equipment
-69K-370K-282K-145K-659K
Acquisitions Net
013K454.66M-2.50M0
Cash generated by investing activities
8.92M63.45M-454.66M-70.32M-115.85M
Financing activities
Common Stock Issued
628K1.32M625.52M135.65M0
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
000014.99M
Cash used in financing activities
628K1.32M625.52M133.13M143.61M
Net Change In Cash
-58.45M-31.32M102.66M26.28M3.33M
Cash at end of period
42.64M101.09M132.42M29.75M3.46M
Data sourceData sourceData sourceData source